CytoMed Therapeutics (NASDAQ:GDTC) Stock Quotes, Forecast and News Summary

Q: What sector and industry does CytoMed Therapeutics (GDTC) operate in?

CytoMed Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

CytoMed Therapeutics Stock (NASDAQ: GDTC) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	105.00 / 12.90K
Day Range	- - -
52 Wk Range	1.20 - 5.50
Market Cap	$27.12M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	53
Short Interest	5.59%
Days to Cover	3.45

Recent News

Why Container Store Group Shares Are Trading Lower By Around 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of The Container Store Group, Inc. (NYSE: TCS) shares fell sharply during Wednesday’s session following weak quarterly results.

Avi Kapoor

US Stocks Gain; Uber Posts Upbeat Sales

U.S. stocks traded higher this morning, with the Dow Jones gaining around 100 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.25% to 38,618.79 while the NASDAQ rose 0.34% to 15,661.70. The S&P 500 also rose, gaining, 0.34% to 4,971.18.

Avi Kapoor

Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jun

Oct

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	105.00 / 12.90K
Day Range	- - -
52 Wk Range	1.20 - 5.50
Market Cap	$27.12M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	53
Short Interest	5.59%
Days to Cover	3.45

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy CytoMed Therapeutics (GDTC) stock?

You can purchase shares of CytoMed Therapeutics (NASDAQ:GDTC) through any online brokerage.

View our list of the best stock brokerages

Who are CytoMed Therapeutics (GDTC) competitors?

Other companies in CytoMed Therapeutics’s space includes: Acurx Pharmaceuticals (NASDAQ:ACXP), Bolt Biotherapeutics (NASDAQ:BOLT), Geovax Labs (NASDAQ:GOVX), GlycoMimetics (NASDAQ:GLYC) and Longeveron (NASDAQ:LGVN).

What is the forecast, or price target, for CytoMed Therapeutics (GDTC) stock?

CytoMed Therapeutics has a consensus price target of $5.00.

What is the current price for CytoMed Therapeutics (GDTC)?

The stock price for CytoMed Therapeutics (NASDAQ: GDTC) is $2.35 last updated November 21, 2024 at 7:59 AM EST.

Does CytoMed Therapeutics (GDTC) pay a dividend?

There are no upcoming dividends for CytoMed Therapeutics.

When is CytoMed Therapeutics (NASDAQ:GDTC) reporting earnings?

CytoMed Therapeutics does not have any upcoming earnings scheduled.

Is CytoMed Therapeutics (GDTC) going to split?

There is no upcoming split for CytoMed Therapeutics.

What sector and industry does CytoMed Therapeutics (GDTC) operate in?

CytoMed Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

CytoMed Therapeutics

CytoMed Therapeutics (GDTC) Forecast